advertisement

Topcon

Abstract #18370 Published in IGR 3-3

Beta-adrenergic antagonists in the treatment of glaucoma

Gandolfi ; Cimino L
European Journal of Ophthalmology 2001; 11: Suppl 2 S63-S66


PURPOSE: Beta-blockers have been used since the late 1970s as 'first-choice' in the treatment of glaucoma. Since the introduction of new molecules into clinical routine, discussion on the current role of beta-blockers in glaucoma therapy have reopened. In particular, concerns have been raised regarding their actual safety profile. METHODS: This review focuses on the latest advances on the efficacy and safety profiles of non-selective beta-blockers. CONCLUSION: The data provided should help to trace a more appropriate role for beta-blockers in glaucoma therapy.

Dr S.A. Gandolfi, Istituto di Oftalmologia, Via Gramsci, 14, 43100 Parma, Italy. s.gandolfi@rsadvnet.it


Classification:

11.3.4 Betablocker (Part of: 11 Medical treatment > 11.3 Adrenergic drugs)



Issue 3-3

Change Issue


advertisement

WGA Rescources